Global Medicine Pipeline Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI11245205

Publication Date:

November 12, 2024

Pages:

102

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The Medicine pipeline refers to a series of steps and processes taken by pharmaceutical companies or research institutions when discovering and developing new drugs. These steps usually include drug discovery, preclinical research, clinical trials, application for marketing, and post-marketing research and monitoring. The purpose of the drug pipeline is to ensure that new drugs meet standards in terms of safety and efficacy so that they can be successfully marketed and used to treat diseases.
The global Medicine Pipeline market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (publisher)' newest research report, the 鈥淢edicine Pipeline Industry Forecast鈥� looks at past sales and reviews total world Medicine Pipeline sales in 2022, providing a comprehensive analysis by region and market sector of projected Medicine Pipeline sales for 2023 through 2029. With Medicine Pipeline sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medicine Pipeline industry.
This Insight Report provides a comprehensive analysis of the global Medicine Pipeline landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Medicine Pipeline portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Medicine Pipeline market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medicine Pipeline and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medicine Pipeline.
United States market for Medicine Pipeline is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Medicine Pipeline is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Medicine Pipeline is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Medicine Pipeline players cover Roche, Pfizer, AstraZeneca, Eli Lilly, Bristol Myers Squibb, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Medicine Pipeline market by product type, application, key players and key regions and countries.
Segmentation by Type:
Innovative Drugs
Generic Drugs
Segmentation by Application:
Pharmaceutical Industry
Biotechnology
Public Health
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Innovative Drugs
Generic Drugs
Segmentation by Application:
Pharmaceutical Industry
Biotechnology
Public Health
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche
Pfizer
AstraZeneca
Eli Lilly
Bristol Myers Squibb
Novartis
Johnson & Johnson
Jiangsu Hengrui Pharmaceuticals
Merck
Sanofi
APC
AbbVie
Moderna
Prime Medicine

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Medicine Pipeline Market Size 2019-2030
2.1.2 Medicine Pipeline Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Medicine Pipeline by Country/Region, 2019, 2023 & 2030
2.2 Medicine Pipeline Segment by Type
2.2.1 Innovative Drugs
2.2.2 Generic Drugs
2.3 Medicine Pipeline Market Size by Type
2.3.1 Medicine Pipeline Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Medicine Pipeline Market Size Market Share by Type (2019-2024)
2.4 Medicine Pipeline Segment by Application
2.4.1 Pharmaceutical Industry
2.4.2 Biotechnology
2.4.3 Public Health
2.4.4 Others
2.5 Medicine Pipeline Market Size by Application
2.5.1 Medicine Pipeline Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Medicine Pipeline Market Size Market Share by Application (2019-2024)
3 Medicine Pipeline Market Size by Player
3.1 Medicine Pipeline Market Size Market Share by Player
3.1.1 Global Medicine Pipeline Revenue by Player (2019-2024)
3.1.2 Global Medicine Pipeline Revenue Market Share by Player (2019-2024)
3.2 Global Medicine Pipeline Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Medicine Pipeline by Region
4.1 Medicine Pipeline Market Size by Region (2019-2024)
4.2 Global Medicine Pipeline Annual Revenue by Country/Region (2019-2024)
4.3 Americas Medicine Pipeline Market Size Growth (2019-2024)
4.4 APAC Medicine Pipeline Market Size Growth (2019-2024)
4.5 Europe Medicine Pipeline Market Size Growth (2019-2024)
4.6 Middle East & Africa Medicine Pipeline Market Size Growth (2019-2024)
5 Americas
5.1 Americas Medicine Pipeline Market Size by Country (2019-2024)
5.2 Americas Medicine Pipeline Market Size by Type (2019-2024)
5.3 Americas Medicine Pipeline Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Medicine Pipeline Market Size by Region (2019-2024)
6.2 APAC Medicine Pipeline Market Size by Type (2019-2024)
6.3 APAC Medicine Pipeline Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Medicine Pipeline Market Size by Country (2019-2024)
7.2 Europe Medicine Pipeline Market Size by Type (2019-2024)
7.3 Europe Medicine Pipeline Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Medicine Pipeline by Region (2019-2024)
8.2 Middle East & Africa Medicine Pipeline Market Size by Type (2019-2024)
8.3 Middle East & Africa Medicine Pipeline Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Medicine Pipeline Market Forecast
10.1 Global Medicine Pipeline Forecast by Region (2025-2030)
10.1.1 Global Medicine Pipeline Forecast by Region (2025-2030)
10.1.2 Americas Medicine Pipeline Forecast
10.1.3 APAC Medicine Pipeline Forecast
10.1.4 Europe Medicine Pipeline Forecast
10.1.5 Middle East & Africa Medicine Pipeline Forecast
10.2 Americas Medicine Pipeline Forecast by Country (2025-2030)
10.2.1 United States Market Medicine Pipeline Forecast
10.2.2 Canada Market Medicine Pipeline Forecast
10.2.3 Mexico Market Medicine Pipeline Forecast
10.2.4 Brazil Market Medicine Pipeline Forecast
10.3 APAC Medicine Pipeline Forecast by Region (2025-2030)
10.3.1 China Medicine Pipeline Market Forecast
10.3.2 Japan Market Medicine Pipeline Forecast
10.3.3 Korea Market Medicine Pipeline Forecast
10.3.4 Southeast Asia Market Medicine Pipeline Forecast
10.3.5 India Market Medicine Pipeline Forecast
10.3.6 Australia Market Medicine Pipeline Forecast
10.4 Europe Medicine Pipeline Forecast by Country (2025-2030)
10.4.1 Germany Market Medicine Pipeline Forecast
10.4.2 France Market Medicine Pipeline Forecast
10.4.3 UK Market Medicine Pipeline Forecast
10.4.4 Italy Market Medicine Pipeline Forecast
10.4.5 Russia Market Medicine Pipeline Forecast
10.5 Middle East & Africa Medicine Pipeline Forecast by Region (2025-2030)
10.5.1 Egypt Market Medicine Pipeline Forecast
10.5.2 South Africa Market Medicine Pipeline Forecast
10.5.3 Israel Market Medicine Pipeline Forecast
10.5.4 Turkey Market Medicine Pipeline Forecast
10.6 Global Medicine Pipeline Forecast by Type (2025-2030)
10.7 Global Medicine Pipeline Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Medicine Pipeline Forecast
11 Key Players Analysis
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Medicine Pipeline Product Offered
11.1.3 Roche Medicine Pipeline Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Medicine Pipeline Product Offered
11.2.3 Pfizer Medicine Pipeline Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Pfizer Main Business Overview
11.2.5 Pfizer Latest Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Company Information
11.3.2 AstraZeneca Medicine Pipeline Product Offered
11.3.3 AstraZeneca Medicine Pipeline Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 AstraZeneca Main Business Overview
11.3.5 AstraZeneca Latest Developments
11.4 Eli Lilly
11.4.1 Eli Lilly Company Information
11.4.2 Eli Lilly Medicine Pipeline Product Offered
11.4.3 Eli Lilly Medicine Pipeline Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Eli Lilly Main Business Overview
11.4.5 Eli Lilly Latest Developments
11.5 Bristol Myers Squibb
11.5.1 Bristol Myers Squibb Company Information
11.5.2 Bristol Myers Squibb Medicine Pipeline Product Offered
11.5.3 Bristol Myers Squibb Medicine Pipeline Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Bristol Myers Squibb Main Business Overview
11.5.5 Bristol Myers Squibb Latest Developments
11.6 Novartis
11.6.1 Novartis Company Information
11.6.2 Novartis Medicine Pipeline Product Offered
11.6.3 Novartis Medicine Pipeline Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Novartis Main Business Overview
11.6.5 Novartis Latest Developments
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Information
11.7.2 Johnson & Johnson Medicine Pipeline Product Offered
11.7.3 Johnson & Johnson Medicine Pipeline Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Johnson & Johnson Main Business Overview
11.7.5 Johnson & Johnson Latest Developments
11.8 Jiangsu Hengrui Pharmaceuticals
11.8.1 Jiangsu Hengrui Pharmaceuticals Company Information
11.8.2 Jiangsu Hengrui Pharmaceuticals Medicine Pipeline Product Offered
11.8.3 Jiangsu Hengrui Pharmaceuticals Medicine Pipeline Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Jiangsu Hengrui Pharmaceuticals Main Business Overview
11.8.5 Jiangsu Hengrui Pharmaceuticals Latest Developments
11.9 Merck
11.9.1 Merck Company Information
11.9.2 Merck Medicine Pipeline Product Offered
11.9.3 Merck Medicine Pipeline Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Merck Main Business Overview
11.9.5 Merck Latest Developments
11.10 Sanofi
11.10.1 Sanofi Company Information
11.10.2 Sanofi Medicine Pipeline Product Offered
11.10.3 Sanofi Medicine Pipeline Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Sanofi Main Business Overview
11.10.5 Sanofi Latest Developments
11.11 APC
11.11.1 APC Company Information
11.11.2 APC Medicine Pipeline Product Offered
11.11.3 APC Medicine Pipeline Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 APC Main Business Overview
11.11.5 APC Latest Developments
11.12 AbbVie
11.12.1 AbbVie Company Information
11.12.2 AbbVie Medicine Pipeline Product Offered
11.12.3 AbbVie Medicine Pipeline Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 AbbVie Main Business Overview
11.12.5 AbbVie Latest Developments
11.13 Moderna
11.13.1 Moderna Company Information
11.13.2 Moderna Medicine Pipeline Product Offered
11.13.3 Moderna Medicine Pipeline Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Moderna Main Business Overview
11.13.5 Moderna Latest Developments
11.14 Prime Medicine
11.14.1 Prime Medicine Company Information
11.14.2 Prime Medicine Medicine Pipeline Product Offered
11.14.3 Prime Medicine Medicine Pipeline Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Prime Medicine Main Business Overview
11.14.5 Prime Medicine Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂